Evidence of suboptimal management of cardiovascular risk in patients with type 2 diabetes mellitus and symptomatic atherosclerosis
about
Evidence based practice in postgraduate healthcare education: a systematic reviewCardiovascular risk in patients with type 2 diabetesIs aspirin effective in diabetic patients? NoAdherence to cardioprotective medications and mortality among patients with diabetes and ischemic heart diseaseEvaluation of the uses of aspirin, statins and ACEIs/ARBs in a diabetes outpatient population in southern ThailandGeneral practitioners knowledge and management of whiplash associated disorders and post-traumatic stress disorder: implications for patient careThe development of a guideline implementability tool (GUIDE-IT): a qualitative study of family physician perspectivesMaking sense of complex data: a mapping process for analyzing findings of a realist review on guideline implementability.Utilization of diabetes medication and cost of testing supplies in Saskatchewan, 2001Case management for blood pressure and lipid level control after minor stroke: PREVENTION randomized controlled trial.Reaching beyond the review of research evidence: a qualitative study of decision making during the development of clinical practice guidelines for disease prevention in healthcare.The preventing recurrent vascular events and neurological worsening through intensive organized case-management (PREVENTION) trial protocol [clinicaltrials.gov identifier: NCT00931788].Influence of dyslipidemia in control of arterial hypertension among type-2 diabetics in the western region of the Republic of MacedoniaTreatment gaps in the management of cardiovascular risk factors in patients with type 2 diabetes in Canada.Efficacy of intensive multitherapy for patients with type 2 diabetes mellitus: a randomized controlled trial.Effect of adding pharmacists to primary care teams on blood pressure control in patients with type 2 diabetes: a randomized controlled trial."More bang for the buck": exploring optimal approaches for guideline implementation through interviews with international developersType 2 diabetes does not increase risk of depressionHow can we improve guideline use? A conceptual framework of implementabilitySuboptimal use of risk reduction therapy in peripheral arterial disease patients at a major teaching hospitalAdherence to the American Diabetes Association standards of care among patients with type 2 diabetes in primary care in Saudi Arabia.Understanding the relationship between the perceived characteristics of clinical practice guidelines and their uptake: protocol for a realist reviewAn exploration of how guideline developer capacity and guideline implementability influence implementation and adoption: study protocolDeficiencies in the quality of diabetes care: comparing specialist with generalist care misses the point.Do physician outcome judgments and judgment biases contribute to inappropriate use of treatments? Study protocol.The guideline implementability research and application network (GIRAnet): an international collaborative to support knowledge exchange: study protocol.Atherosclerotic disease and risk factor modification in Saudi Arabia: a call to action.Integrating guideline development and implementation: analysis of guideline development manual instructions for generating implementation advice.Blood pressure and lipid management fall far short in persons with type 2 diabetes: results from the DIAB-CORE Consortium including six German population-based studies.How do surgeons decide to refer patients for adjuvant cancer treatment? Protocol for a qualitative studyPROactive 07: pioglitazone in the treatment of type 2 diabetes: results of the PROactive study.Family practice patients' use of acetylsalicylic acid for cardiovascular disease prevention.Treatment and blood pressure control in 47,964 people with diabetes and hypertension: a systematic review of observational studies.The effect of specialist care within the first year on subsequent outcomes in 24,232 adults with new-onset diabetes mellitus: population-based cohort study.Patterns of medical therapy in patients with peripheral artery disease in a tertiary care centre in CanadaHow many cardiovascular events can be prevented with optimal management of high-risk Canadians?Cardiovascular outcomes in framingham participants with diabetes: the importance of blood pressure.Individualized electronic decision support and reminders to improve diabetes care in the community: COMPETE II randomized trial.Control of risk factors among people with diagnosed diabetes, by lower extremity disease statusA review of simple, non-invasive means of assessing peripheral arterial disease and implications for medical management.
P2860
Q21254585-A72FE31C-7A23-498E-85F9-46685BE72972Q28174308-87C94935-B3D2-4ED3-8308-417F43BA4946Q28193980-E6FB25CC-A366-4033-8345-FC1264F239A8Q28212736-38A113FB-8474-4E70-9D0C-777DEFC1500DQ28221323-8150959C-1A05-4053-8314-6FD544691A80Q28384609-E1666534-5A21-4E53-A9D3-A4573B8F5B94Q30577817-9819EE56-CDB5-49A1-9285-0BE84E639E50Q30666453-D6E02E82-AB0D-4C27-B452-36A3B42E85BFQ33266312-D88A6A34-A639-4CB6-9E8A-154E9E4F6C5CQ33590541-3491F6D7-8F84-4266-82B1-1BFD6BC28CC9Q33660362-509FB97C-091F-41F7-8FF3-433379A08DBBQ33843433-3AD31CF2-F560-4BE4-8D67-41AAF3FD028FQ33847033-FC4CE89D-8821-453D-BF56-C179A230A22CQ33994044-3F05F08F-426F-4C21-B97C-0A03E3C05B35Q34229170-F670D1E0-ED72-4615-8967-E90DFAF83C48Q34422037-7A94FE9A-7C69-4963-8107-3D7137F8FF04Q34478206-48584931-0985-4D43-ADA0-C31B44592151Q34695996-44CC24FC-2207-4D88-90B2-B2D08056E07DQ34774263-1A5489EE-7686-4AF4-B274-0A87BFA8E375Q35165801-6339FFD9-F2DC-45F0-9B24-7F8A06428F4FQ35222082-C1129235-7378-4FDD-B28B-892F8CB75993Q35574319-D630DAF1-4EED-45DB-AFBA-CA3A7FD4D5F4Q35575465-8A8C7D23-6E4E-44D8-953C-46CA18B048BCQ35683068-EEC166FE-792B-43BA-B9E2-062A945A5A5EQ35855776-627AD081-381C-4484-97EC-B9D21E6FCD65Q35916903-6789FAF8-B382-433F-96D5-6E34F63526BBQ36027227-A6C80BA7-23F9-4A46-900C-DA6C553F452EQ36278637-E901C2DE-8C8A-46D5-B067-E71C1882C263Q36281537-080F3520-E875-487F-A53F-9AB79DB08944Q36416460-1AB5FBF7-27DE-4369-80B5-771C9A3D5CBFQ36536316-49C5758F-D6E5-4474-8DCE-DB9A8E3F3854Q36564342-3A8897E6-1E76-48F1-9F88-A400B581F298Q36587618-D6BD960C-FE79-430F-9D01-0488FA080D26Q36767335-AE466DCC-4B2C-4E7D-92B0-C087FDBA04F6Q36794337-677553E7-C9AE-4812-928F-A248FD8E995AQ37098243-85AD3A51-6A95-4455-91C0-044EBD4164A5Q37202122-E2BCD117-BE71-4FFF-89EF-D4A35F47C6DAQ37246977-650C3590-C180-4AB4-9B70-E7855BDB392BQ37414860-434153CA-A522-416E-99CF-D44BEA0CE077Q37692405-D9CCADDB-1089-4DA0-8CF2-5701E2DE5A0B
P2860
Evidence of suboptimal management of cardiovascular risk in patients with type 2 diabetes mellitus and symptomatic atherosclerosis
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh
2004年學術文章
@zh-hant
name
Evidence of suboptimal managem ...... nd symptomatic atherosclerosis
@en
Evidence of suboptimal managem ...... d symptomatic atherosclerosis.
@nl
type
label
Evidence of suboptimal managem ...... nd symptomatic atherosclerosis
@en
Evidence of suboptimal managem ...... d symptomatic atherosclerosis.
@nl
prefLabel
Evidence of suboptimal managem ...... nd symptomatic atherosclerosis
@en
Evidence of suboptimal managem ...... d symptomatic atherosclerosis.
@nl
P2093
P2860
P921
P356
P1476
Evidence of suboptimal managem ...... nd symptomatic atherosclerosis
@en
P2093
Finlay A McAlister
Lauren C Brown
Ross T Tsuyuki
Sumit R Majumdar
P2860
P304
P356
10.1503/CMAJ.1031965
P407
P577
2004-11-01T00:00:00Z